CIRM funds stem cell research to institutions throughout California. On the map below, click on any marker to learn more about our funding to that institution. You can explore the awards they’ve ...

Some years ago it was discovered that patients homozygous for a natural mutation (the Δ32 mutation) in the CCR5 gene are generally resistant to HIV infection by blocking virus entry to a cell.

When most people think about about stem cells treating disease they think of a stem cell transplant. In a stem cell transplant, stem cells are first specialized into the necessary adult cell type.

Welcome to the frequently asked questions (FAQs) page of the California Institute for Regenerative Medicine (CIRM). Here, you’ll find answers to the most common questions you may have on CIRM. CIRM, ...

Foundation – Discovery Stage Research Projects Xiaojie Qiu Mapping and modeling endothelial cell fate decisions for pulmonary arterial hypertension $1,540,798 Foundation – Discovery Stage Research ...

The following information will help you comply with CIRM regulations and find information about our forms and policies. If you have questions that aren’t addressed on this page contact your Grants ...

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and ...

La enfermedad granulomatosa crónica ligada al cromosoma X (X-CGD) es un trastorno inmunitario poco frecuente que impide que los glóbulos blancos maten a los invasores extraños. Esto provoca ...

At the California Institute for Regenerative Medicine (CIRM), we are committed to the continued funding of groundbreaking research in regenerative medicine. To reflect this commitment, we are ...

CIRM is dedicated to bringing regenerative medicine treatments to patients who need them. This commitment begins with access to information. This page provides resources to learn more about ...

Quest – Discovery Stage Research Projects Dr. Alan D. Agulnick Preclinical development of an immune evasive islet cell replacement therapy for type 1 diabetes $1,470,987 Clinical Trial Stage Projects ...